Significant macro risks persist, such as increased government interference in business, the revision of earlier privatisations and corruption, particularly at regional and local levels and currency volatility. The enforcement of patent laws and other regulations will likely remain weak, while the courts are a costly and unreliable last resort. ...The enforcement of patent laws and other regulations will likely remain weak, while the courts are a costly and unreliable last resort. Plans designed to increase the share of domestically produced pharmaceuticals will continue to drive the rising state control over the sector. Tensions with Western powers threaten to spill over into tit-for-tat sanctions or trade restrictions on imported goods. ...Tensions with Western powers threaten to spill over into tit-for-tat sanctions or trade restrictions on imported goods. Measures to increase generic prescribing will increase the threat from cheap copycat drugs.
...In May ----, the Federal Antimonopoly Service (FAS) reported that Russian drugmakers were slashing the production of drugs on the Vital and Essential Medicines List due to the current economic recession and excessive pricing controls. According to the FAS, a total of --- drugs priced at or below RUB-- (USD-.--) have been removed from production, with another --- expected to follow suit. In April ----, the Kremlin and the FAS were considering amendments to the Russian Civil Code with respect to drug manufacturing. The government wants to allow domestic firms to produce foreign drugs without the permission of the patent holder. ...The government wants to allow domestic firms to produce foreign drugs without the permission of the patent holder.
...BMI View: Russia s healthcare market is in a precarious position due to a severe lack of funding and an escalating burden of disease. The country s economic recession will see further pressure placed on the population for provision of care. ...
